查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
3D打印藥品市場規模、份額和趨勢分析報告：按技術（噴墨打印、Zipdose 技術、立體光刻）、應用（骨科、神經病學）、用途、地區、細分市場預測2022-2030
市場調查報告書
商品編碼
1114023

3D打印藥品市場規模、份額和趨勢分析報告：按技術（噴墨打印、Zipdose 技術、立體光刻）、應用（骨科、神經病學）、用途、地區、細分市場預測2022-2030

3D Printed Drugs Market Size, Share & Trends Analysis Report By Technology (Inkjet Printing, Zipdose Technology, Stereolithography), By Application (Orthopedic, Neurology), By End-use, Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

3D 打印藥品市場增長和趨勢

根據 Grandview Research 的一份新報告，到 2030 年，全球 3D 打印藥品市場預計將達到 2.6974 億美元。

預計從 2022 年到 2030 年，市場將以 15.32% 的複合年增長率增長。慢性病患病率上升，加上全球吞嚥困難患者人數不斷增加，預計將增加對快速溶解藥物的需求並推動市場發展。例如，2022 年 4 月發表的一項研究報告稱，在中風和衰老等情況下，口咽性吞嚥困難的患病率更高，在老年人中為 26.19%。

隨著社會老齡化，對老年人易吞服藥片的開發需求越來越大。 3D 打印的高溶解性、易於吞嚥的藥物可以幫助吞嚥困難的老年人。此外，根據聯合國的數據，到 2050 年，65 歲及以上的人口將達到 15 億。因此，預計全球老齡化人口的增加將推動對易吞服藥物的需求，從而推動市場增長。

其他因素，例如藥品需求的快速增長、醫療保健技術的改進，以及政府對 3D 打印行業的關注和支出，都在推動市場的增長。例如，2022 年 3 月，贏創風險投資投資了總部位於內華達州的 Laxxon Medical，以生產 3D 打印平板電腦。後者公司開發了一種 3D 絲網印刷技術來生產結構化片劑，並隨著時間的推移控制 API 的釋放。預計這些投資將在未來幾年補充市場增長。

預計 COVID-19 疫情將對市場增長產生積極影響。領先的製造公司已經推出了幾台打印機，以幫助增加藥品和其他所需產品的產量。因此，在 COVID-19 流行期間，這些技術的使用預計會增加。

預計對個性化醫療的不斷增長的需求將在未來幾年顯著推動市場增長。預計在不久的將來，市場將呈指數級增長，因為藥品的 3D 打印可以生產小批量的個性化藥品，這些藥品具有精心定制的形狀、劑量和尺寸。此外，利用3D打印技術可以顯著降低製造成本，有望進一步加大該領域的投資力度。

另一方面，這些藥物的副作用、使用 3D 打印製造非法藥物以及政府對 3D 打印產品缺乏監管限制了市場的增長。例如，2018 年 3 月，阿姆斯特丹警方因非法交易這些毒品而受到抨擊。然而，提高對這些藥物益處的認識，例如即時溶解、減少製造時間、減少浪費和易於按需製造，可能會為市場增長創造多種前景。

3D 打印藥品市場報告亮點

就技術而言，Zipdose 細分市場在 3D 市場中佔有最大份額。這是由於對在口腔中快速分散的快速溶解藥物的需求不斷增長，從而導致採用率增加和市場增長。

預計噴墨打印機細分市場在預測期內將出現良好增長。由於 3D 藥物可以根據每位患者的需求進行定制，因此它們所幫助的患者數量遠遠超過批量生產的藥物，預計未來幾年對它們的需求將猛增。

從應用來看，神經領域在全球市場佔有很大份額。這被認為是由於老年人口的比例越來越高，他們患神經系統疾病的風險很高，從而促進了市場的增長。

由於對個性化醫療的需求不斷增長以及採用該技術的生物製藥的成本效益利用，醫院和診所部分在 2021 年佔最終用戶的很大份額。

由於技術先進的醫療保健研究框架的可用性、高研發投資的存在以及該地區 3D 打印藥物的開發，北美將在 2021 年主導全球市場。

由於慢性病患病率的上升和主要參與者的存在，預計亞太地區未來將顯著增長。

主要市場參與者的示例包括 3D 打印機和製藥機、Aprcia Pharmaceuticals、BV LLC、Hewlett Packard Caribe 等。

內容

第1章研究方法

  • 市場細分和範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • Gvr 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算國別市場
  • 全球市場：CAGR 計算
  • 調查假設
  • 輔助信息列表
  • 主要信息列表
  • 目的
  • 縮寫列表

第 2 章市場定義

第 3 章執行摘要

  • 市場概覽

第 4 章全球 3D 打印藥品市場變量、趨勢和範圍

  • 3D 打印藥品市場的譜系展望
    • 母公司市場展望
  • 繪製滲透率和增長前景
  • 監管框架
  • 市場驅動因素分析
    • 越來越多地使用 3D 打印在醫療行業
    • 越來越多地採用個性化藥物
    • 3D 打印在各行業的多種應用
    • 對速溶片的高需求
    • COVID-19 爆發
  • 市場約束分析
    • 3D 打印藥品的限制
    • 政府對 3D 打印產品缺乏監管
  • 市場機會分析
    • 提高對 3D 打印技術的認識和採用
  • 波特五力分析
  • 管道分析

第 5 章 3D 打印市場 - 細分分析，按技術，2018-2030 年（百萬美元）

  • 全球 3D 打印藥品市場：技術波動分析
  • 噴墨打印
  • 熔融沈積建模
  • 立體光刻
  • ZipDose 技術

第 6 章 3D 打印藥品市場 - 細分分析，按應用，2018-2030 年（百萬美元）

  • 全球 3D 打印藥品市場：應用波動分析
  • 骨科
  • 神經科
  • 牙科
  • 其他

第 7 章 3D 打印藥品市場細分分析，按最終用戶，2018-2030 年（百萬美元）

  • 3D 打印藥品市場：最終用戶波動分析
  • 醫院和診所
  • 調查
  • 其他

第 8 章 3D 打印藥品市場：- 細分分析，按地區，2018-2030 年（百萬美元）

  • 3D 打印藥品市場：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中東和非洲 (MEA)
    • 南非
    • 沙特阿拉伯

第 9 章競爭格局

  • 上市公司
    • 公司市場分析
    • 競爭信息中心分析
    • 戰略框架
  • 非上市公司
    • 主要初創企業/技術顛覆者/創新者列表
    • 本地網絡地圖
  • 公司簡介
    • APRECIA PHARMACEUTICALS LLC
      • 公司簡介
      • Aller Co., Ltd.
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 擴展生物科學
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 比奧杜羅
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 親和力療法
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • OSMOTICA PHARMACEUTICALS
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • ACRUX
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 葛蘭素史克公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 惠普加勒比
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 默克
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 循環製藥
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 阿斯利康
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • FABRX LTD.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-951-6

3D Printed Drugs Market Growth & Trends:

The global 3D printed drugs market is expected to reach USD 269.74 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is pushing the demand for immediate soluble medications, which is likely to drive the market. For instance, according to a study published in April 2022, the prevalence of oropharyngeal dysphagia is high in conditions such as stroke and aging and is reported to be 26.19% in the elderly.

An increase in the aging population has led to the growing demand for the development of easy-to-swallow pills for the elderly. The 3D printed highly soluble and easy-to-swallow drugs can help the elderly who have difficulty swallowing. Moreover, according to the United Nations, the number of people aged 65 and more in 2050 is projected to be 1.5 billion. Thus, the growing elderly population across the world would propel the demand for easy-to-swallow drugs resulting in market growth.

Other factors such as quickly expanding demand for pharmaceuticals, technical improvements in healthcare, as well as the government's focus and expenditures in the 3D printing industry, are also contributing to the market's growth. For instance, in March 2022, Evonik Venture Capital invested in Nevada-based Laxxon Medical for the manufacturing of 3D-printed tablets. The latter company has developed a 3D screen-printing technology for the production of structured tablets with the controlled release of API over time. Such investments are likely to supplement the market growth in the coming years.

The COVID-19 pandemic is anticipated to positively impact market growth. Several printers have been launched by the operating companies in the advanced manufacturing industry to help increase the manufacturing of medications and other necessary products. As a result, the usage of these technologies is projected to increase during the COVID-19 pandemic.

The growing demand for personalized medicine is expected to majorly drive market growth in the coming years. As 3D printing of pharmaceutical drugs can produce personalized medicine in small batches with carefully tailored shapes, dosages, and sizes, the market is anticipated to grow at an exponential rate in the near future. In addition, the use of 3D printing technology can significantly reduce manufacturing costs thus, further increasing investments in this space.

On the other hand, adverse effects from these drugs, the use of 3D printing to create illegal drugs, and a lack of government restrictions for 3D printed products are limiting the market's growth. For instance, in March 2018, a police case was filed in Amsterdam, for the illegal handling of these drugs. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

3D Printed Drugs Market Report Highlights:

  • By technology, the zip dose segment held the largest share of the 3D market. This is attributed to the increase in the requirement for rapid soluble drugs that disperse quickly in the mouth, which in turn is likely to increase the adoption and anticipate market growth.
  • The inkjet printer segment is expected to grow lucratively during the forecast period. Due to the 3D medications can be personalized to each patient's needs, assisting them far more than batch-produced medicines, their demand is expected to skyrocket in the coming years.
  • By application, the neurology segment held a larger share of the global market. This is attributed to an increase in the proportion of older people, which is at an increased risk of developing neurological disorders and hence, propelling the market growth.
  • By end-use, the hospitals & clinics segment held a larger share in 2021, owing to the growing demand for personalized medicines and the cost-effective use of bio-drugs employing this technology.
  • North America dominated the global market in 2021 due to the availability of technologically advanced healthcare research framework, the presence of high R&D investment, and the development of 3D printed drugs in the region.
  • The Asia Pacific is expected to grow considerably in the future owing to the rising prevalence of chronic diseases and the presence of key players.
  • A few of the key market players include 3D Printer Drug Machine, Aprecia Pharmaceuticals, BV LLC, Hewlett Packard Caribe, and others.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global 3D Printed Drugs Market Variables, Trends, & Scope

  • 4.1 3D Printed Drugs Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Driver Analysis
    • 4.4.1 Rising Usage Of 3D Printing In The Medical Industries
    • 4.4.2 Increasing Adoption Of Personalized Drugs
    • 4.4.3 Multiple Applications Of 3D Printing In Various Industries
    • 4.4.4 High Demand For Instantaneous Soluble Tablets
    • 4.4.5 Outbreak Of Covid-19
  • 4.5 Market Restraint Analysis
    • 4.5.1 Limitations Of 3D Printed Medicines
    • 4.5.2 Lack Of Government Regulations For 3D Printed Products
  • 4.6 Market Opportunity Analysis
    • 4.6.1 Rising Awareness And Adoption Of The 3D Printing Technology
  • 4.7 Porter's Five Forces Analysis
  • 4.8 Pipeline Analysis

Chapter 5 3D Printed Market - Segment Analysis, by technology, 2018 - 2030 (USD Million)

  • 5.1 Global 3D Printed Drugs Market: Technology Movement Analysis
  • 5.2 Inkjet Printing
    • 5.2.1 Inkjet Printing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Fused Deposition Modeling
    • 5.3.1 Fused Deposition Modeling Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Stereolithography
    • 5.4.1 Stereolithography Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 ZipDose Technology
    • 5.5.1 Zipdose Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 3D Printed Drugs Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 6.1 Global 3D Printed Drugs Market: Application Movement Analysis
  • 6.2 Orthopedic
    • 6.2.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Neurology
    • 6.3.1 Neurology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Dental
    • 6.4.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 3D Printed Drugs Market- Segment Analysis, By End-User, 2018 - 2030 (USD Million)

  • 7.1 3D Printed Drugs Market: End-User Movement Analysis
  • 7.2 Hospitals & Clinics
    • 7.2.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Research Laboratories
    • 7.3.1 Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 3D Printed Drugs Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 3D Printed Drugs Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Public Companies
    • 9.1.1 Company Market Position Analysis
    • 9.1.2 Competitive Dashboard Analysis
    • 9.1.3 Strategic Framework
  • 9.2 Private Companies
    • 9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 9.2.2 Regional Network Map
  • 9.3 Company Profiles
    • 9.3.1 APRECIA PHARMACEUTICALS LLC
      • 9.3.1.1 Company Overview
      • 9.3.1.2 Alere, Inc.
      • 9.3.1.3 Financial Performance
      • 9.3.1.4 Product Benchmarking
      • 9.3.1.5 Strategic Initiatives
    • 9.3.2 EXTEND BIOSCIENCES
      • 9.3.2.1 Company Overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product Benchmarking
      • 9.3.2.4 Strategic Initiatives
    • 9.3.3 BIODURO
      • 9.3.3.1 Company Overview
      • 9.3.3.2 Financial Performance
      • 9.3.3.3 Product Benchmarking
      • 9.3.3.4 Strategic Initiatives
    • 9.3.4 AFFINITY THERAPEUTICS
      • 9.3.4.1 Company Overview
      • 9.3.4.2 Financial Performance
      • 9.3.4.3 Product Benchmarking
      • 9.3.4.4 Strategic Initiatives
    • 9.3.5 OSMOTICA PHARMACEUTICALS
      • 9.3.5.1 Company Overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product Benchmarking
      • 9.3.5.4 Strategic Initiatives
    • 9.3.6 ACRUX
      • 9.3.6.1 Company Overview
      • 9.3.6.2 Financial Performance
      • 9.3.6.3 Product Benchmarking
      • 9.3.6.4 Strategic Initiatives
    • 9.3.7 GLAXOSMITHKLINE PLC
      • 9.3.7.1 Company Overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product Benchmarking
      • 9.3.7.4 Strategic Initiatives
    • 9.3.8 HEWLETT PACKARD CARIBE
      • 9.3.8.1 Company Overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product Benchmarking
      • 9.3.8.4 Strategic Initiatives
    • 9.3.9 MERCK
      • 9.3.9.1 Company Overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product Benchmarking
      • 9.3.9.4 Strategic Initiatives
    • 9.3.10 CYCLE PHARMACEUTICALS
      • 9.3.10.1 Company Overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product Benchmarking
      • 9.3.10.4 Strategic Initiatives
    • 9.3.11 ASTRAZENECA
      • 9.3.11.1 Company Overview
      • 9.3.11.2 Financial Performance
      • 9.3.11.3 Product Benchmarking
      • 9.3.11.4 Strategic Initiatives
    • 9.3.12 FABRX LTD.
      • 9.3.12.1 Company Overview
      • 9.3.12.2 Financial Performance
      • 9.3.12.3 Product Benchmarking
      • 9.3.12.4 Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 Regulatory Framework
  • TABLE 3 Global 3D printed drugs market estimates and forecasts by technology, 2018 - 2030 (USD Million)
  • TABLE 4 Global 3D printed drugs market estimates and forecasts by application, 2018 - 2030 (USD Million)
  • TABLE 5 3D printed drugs- Key market restraint
  • TABLE 6 Global 3D printed drugs inkjet printing market by region, 2018 - 2030 (USD Million)
  • TABLE 7 Global 3D printed drugs fused deposition modeling market by region, 2018 - 2030 (USD Million)
  • TABLE 8 Global 3D printed drugs stereolithography market by region, 2018 - 2030 (USD Million)
  • TABLE 9 Global 3D printed drugs ZipDose technology market by region, 2018 - 2030 (USD Million)
  • TABLE 10 Global 3D printed drugs demand in orthopedic by region, 2018 - 2030 (USD Million)
  • TABLE 11 Global 3D printed drugs demand in neurology by region, 2018 - 2030 (USD Million)
  • TABLE 12 Global 3D printed drugs demand in dental by region, 2018 - 2030 (USD Million)
  • TABLE 13 Global 3D printed drugs demand in other applications by region, 2018 - 2030 (USD Million)
  • TABLE 14 Global 3D printed drugs demand in hospitals & clinics by region, 2018 - 2030 (USD Million)
  • TABLE 15 Global 3D printed drugs demand in research laboratories by region, 2018 - 2030 (USD Million)
  • TABLE 16 Global 3D printed drugs demand in other end-use by region, 2018 - 2030 (USD Million)
  • TABLE 17 North America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 18 North America 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 19 North America 3D printed drugs market by end-use, 2018 - 2030 (USD Million)
  • TABLE 20 U.S. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 21 U.S. 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 22 U.S. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 23 Canada 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 24 Canada 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 25 Canada 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 26 Europe 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 27 Europe 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 28 Europe 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 29 Germany 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 30 Germany 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 31 Germany 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 32 U.K. 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 33 U.K. 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 34 U.K. 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 35 France 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 36 France 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 37 France 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 38 Italy 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 39 Italy 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 40 Italy 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 41 Spain 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 42 Spain 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 43 Spain 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 44 Asia Pacific 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 45 Asia Pacific 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 47 China 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 48 China 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 49 China 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 50 India 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 51 India 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 52 India 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 53 Japan 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 54 Japan 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 55 Japan 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 56 South Korea 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 57 South Korea 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 58 South Korea 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 59 Latin America 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 60 Latin America 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 61 Latin America 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 62 Brazil 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 63 Brazil 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 64 Brazil 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 65 Mexico 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 66 Mexico 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 67 Mexico 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 68 MEA 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 69 MEA 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 70 MEA 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 71 South Africa 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 72 South Africa 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 73 South Africa 3D printed drugs market by end-user, 2018 - 2030 (USD Million)
  • TABLE 74 Saudi Arabia 3D printed drugs market by technology, 2018 - 2030 (USD Million)
  • TABLE 75 Saudi Arabia 3D printed drugs market by application, 2018 - 2030 (USD Million)
  • TABLE 76 Saudi Arabia 3D printed drugs market by end-user, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 3D printed drugs market segmentation
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Market formulation & validation
  • FIG. 6 Commodity flow analysis
  • FIG. 7 3D printed drugs market snapshot (2021)
  • FIG. 8 Market segmentation
  • FIG. 9 Penetration & growth prospect mapping
  • FIG. 10 Consumer behavior analysis
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Porter's five forces analysis
  • FIG. 15 3D printed drugs market technology outlook: Segment dashboard
  • FIG. 16 3D printed drugs market: Technology movement analysis
  • FIG. 17 Inkjet printing market, 2018 - 2030 (USD Million)
  • FIG. 18 Fused deposition modeling market, 2018 - 2030 (USD Million)
  • FIG. 19 Stereolithography market, 2018 - 2030 (USD Million)
  • FIG. 20 ZipDose Technology market, 2018 - 2030 (USD Million)
  • FIG. 21 3D printed drugs market application outlook: Segment dashboard
  • FIG. 22 3D printed drugs market: Application movement analysis
  • FIG. 23 Orthopedic market, 2018 - 2030 (USD Million)
  • FIG. 24 Neurology market, 2018 - 2030 (USD Million)
  • FIG. 25 Dental market, 2018 - 2030 (USD Million)
  • FIG. 26 Other applications market, 2018 - 2030 (USD Million)
  • FIG. 27 3D printed drugs market end-user outlook: Segment dashboard
  • FIG. 28 3D printed drugs market: End-user movement analysis
  • FIG. 29 Hospitals & clinics market, 2018 - 2030 (USD Million)
  • FIG. 30 Research laboratories market, 2018 - 2030 (USD Million)
  • FIG. 31 Other end-users market, 2018 - 2030 (USD Million)
  • FIG. 32 Regional market: Key takeaways
  • FIG. 33 Regional outlook, 2021 & 2030
  • FIG. 34 North America 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 35 U.S. 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 36 Canada 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 37 Europe 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 38 U.K. 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 39 Germany 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 40 France 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 41 Italy 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 42 Spain 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 43 Asia Pacific 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 44 Japan 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 45 China 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 46 India 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 47 South Korea 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 48 Latin America 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 49 Brazil 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 50 Mexico 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 51 MEA 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 52 South Africa 3D printed drugs market, 2018 - 2030 (USD Million)
  • FIG. 53 Saudi Arabia 3D printed drugs market, 2018 - 2030 (USD Million)